EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder

Sai Sailesh Kumar Goothy, Rohit Singh, Joseph Reel, Rachel Robinson, Wiktoria Ratajczak, Sinead Watson, Jason McKeown

Journal of Affective Disorders · 2025-12 · 391 · 119949

DOI: 10.1016/j.jad.2025.119949 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025-12. Verfasst von Sai Sailesh Kumar Goothy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Indian Center of Neurophysiology, Andhra Pradesh, India; NRI Institute of Medical Sciences, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Major Depressive Disorder, Electric Stimulation Therapy, Vestibular Nerve. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS AND OBJECTIVES: Stimulating the vestibular nerve may influence neurological processes such as prefrontal cortex functions, aiding cognitive flexibility and emotional regulation, important aspects of addressing depressive patterns. This randomized, double-blind, sham-controlled trial aimed to determine the efficacy and safety of a non-invasive electrical vestibular nerve stimulation (VeNS) device as a treatment for major depressive disorder (MDD). MATERIALS AND METHODS: 62 adults (mean age = 43.1 ± 5.0 years) with MDD were randomized to receive an active VeNS device (n = 31) or a sham device (n = 31). Both groups attended the clinic for stimulation sessions (30 min) 5 days per week. The primary outcome was change in Beck's Depression Inventory (BDI-II) score from baseline to week 8. Secondary outcomes were change in Insomnia Severity Index (ISI), Generalized Anxiety Disorder, 7-item (GAD-7), and the EQ-5D-5L Health Utility Index (HUI) scores from baseline to week 8. A post-intervention follow-up was at week 12. RESULTS: After 8 weeks, the active group showed a mean BDI-II score reduction of 6.39 points greater than the sham group (P < 0.001), with scores remaining low during the 4-week post-intervention follow-up. Additionally, the active group, compared with the sham group, showed a significant improvement in ISI (-6.29 vs. 2.23, p < 0.001), GAD-7 (-4.45 vs. -0.32, p < 0.001) and HUI (0.51 vs 0.11, p < 0.001) One minor Adverse Event was reported in the sham group. Formal blinding assessment demonstrated a successful level of blinding was achieved throughout the study. CONCLUSION: VeNS, when delivered over 8-weeks, appears to have a clinically meaningful benefit as an intervention for major depressive disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderElectric Stimulation TherapyVestibular NerveHumansDouble-Blind MethodMaleFemaleAdultMiddle AgedTreatment OutcomePsychiatric Status Rating Scales

Stichwörter der Autor:innen

Major depressive disorderNeurostimulationNon-invasiveRandomized control trialVestibular stimulation

Autor:innen und Institutionen

  • Indian Center of Neurophysiology, Andhra Pradesh, India; NRI Institute of Medical Sciences, Andhra Pradesh, India.
  • NRI Institute of Medical Sciences, Andhra Pradesh, India.
  • Neurovalens Ltd., Belfast, United Kingdom. Electronic address: joe.reel@neurovalens.com.
  • Neurovalens Ltd., Belfast, United Kingdom.
  • Neurovalens Ltd., Belfast, United Kingdom; Dept. of Neurosurgery, Standford University, Palo Alto, USA; School of Medicine, Ulster University, Magee, United Kingdom.

Zitieren

APA

Goothy, S. S. K., Singh, R., Reel, J., Robinson, R., Ratajczak, W., Watson, S., & McKeown, J. (2025). A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder. Journal of Affective Disorders, 391, 119949. https://doi.org/10.1016/j.jad.2025.119949

Vancouver

Goothy SSK, Singh R, Reel J, Robinson R, Ratajczak W, Watson S, et al. A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder. Journal of Affective Disorders. 2025;391:119949. doi:10.1016/j.jad.2025.119949

BibTeX
@article{Goothy2025,
  author = {Goothy, Sai Sailesh Kumar and Singh, Rohit and Reel, Joseph and Robinson, Rachel and Ratajczak, Wiktoria and Watson, Sinead and McKeown, Jason},
  title = {A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder},
  journal = {Journal of Affective Disorders},
  year = {2025},
  volume = {391},
  pages = {119949},
  doi = {10.1016/j.jad.2025.119949}
}
Kostenlos starten →